Fda warns against combination of malaria drug and Gilead's remdesivir
(Reuters) - The U.S. Food and Drug Administration on Monday issued a warning to healthcare providers against administering malaria drug hydroxychloroquine or chloroquine in combination with Gilead Sciences' <GILD.O> experimental COVID-19 drug, remdesivir.
……Read full article on Yahoo - World
Drugs Health News International
One-stop lifestyle app dedicated to making life in Singapore a breeze!
English
简体中文
Comments
Leave a comment in Nestia App